{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:18:56Z","timestamp":1787570336842,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11064-026-04847-y","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T06:18:50Z","timestamp":1784960330000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Octreotide Attenuates Anxiety-Like Behaviors and Cognitive Deficits in a Rat Model of Post-traumatic Stress Disorder"],"prefix":"10.1007","volume":"51","author":[{"given":"Sina","family":"Motamedy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholam Hossein","family":"Meftahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"issue":"15","key":"4847_CR1","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1016\/j.neuron.2021.05.017","volume":"109","author":"TCM Bienvenu","year":"2021","unstructured":"Bienvenu TCM, Dejean C, Jercog D, Aouizerate B, Lemoine M, Herry C (2021) The advent of fear conditioning as an animal model of post-traumatic stress disorder: learning from the past to shape the future of PTSD research. Neuron 109(15):2380\u20132397","journal-title":"Neuron"},{"issue":"1","key":"4847_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41398-020-0806-x","volume":"10","author":"A Verbitsky","year":"2020","unstructured":"Verbitsky A, Dopfel D, Zhang N (2020) Rodent models of post-traumatic stress disorder: behavioral assessment. Translational psychiatry 10(1):132","journal-title":"Translational psychiatry"},{"issue":"7","key":"4847_CR3","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.neubiorev.2006.03.004","volume":"30","author":"A Karl","year":"2006","unstructured":"Karl A, Schaefer M, Malta LS, D\u00f6rfel D, Rohleder N, Werner A (2006) A meta-analysis of structural brain abnormalities in PTSD. Neurosci Biobehav Rev 30(7):1004\u20131031","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"4847_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jad.2005.05.014","volume":"88","author":"N Kitayama","year":"2005","unstructured":"Kitayama N, Vaccarino V, Kutner M, Weiss P, Bremner JD (2005) Magnetic resonance imaging (MRI) measurement of hippocampal volume in posttraumatic stress disorder: a meta-analysis. J Affect Disord 88(1):79\u201386","journal-title":"J Affect Disord"},{"issue":"6","key":"4847_CR5","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/hipo.20102","volume":"15","author":"ME Smith","year":"2005","unstructured":"Smith ME (2005) Bilateral hippocampal volume reduction in adults with post-traumatic stress disorder: a meta-analysis of structural MRI studies. Hippocampus 15(6):798\u2013807","journal-title":"Hippocampus"},{"issue":"7","key":"4847_CR6","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.4088\/JCP.v69n0707","volume":"69","author":"O Bonne","year":"2008","unstructured":"Bonne O, Vythilingam M, Inagaki M, Wood S, Neumeister A, Nugent AC et al (2008) Reduced posterior hippocampal volume in posttraumatic stress disorder. J Clin Psychiatry 69(7):1087\u20131091","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"4847_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3109\/10253890.2015.1094689","volume":"19","author":"AM Whitaker","year":"2016","unstructured":"Whitaker AM, Farooq MA, Edwards S, Gilpin NW (2016) Post-traumatic stress avoidance is attenuated by corticosterone and associated with brain levels of steroid receptor co-activator-1 in rats. Stress 19(1):69\u201377","journal-title":"Stress"},{"key":"4847_CR8","doi-asserted-by":"publisher","first-page":"748372","DOI":"10.3389\/fpsyt.2022.748372","volume":"13","author":"F Murphy","year":"2022","unstructured":"Murphy F, Nasa A, Cullinane D, Raajakesary K, Gazzaz A, Sooknarine V et al (2022) Childhood trauma, the HPA axis and psychiatric illnesses: a targeted literature synthesis. Front Psychiatry 13:748372","journal-title":"Front Psychiatry"},{"issue":"5","key":"4847_CR9","doi-asserted-by":"publisher","first-page":"e1135","DOI":"10.1038\/tp.2017.91","volume":"7","author":"S Muhie","year":"2017","unstructured":"Muhie S, Gautam A, Chakraborty N, Hoke A, Meyerhoff J, Hammamieh R et al (2017) Molecular indicators of stress-induced neuroinflammation in a mouse model simulating features of post-traumatic stress disorder. Translational psychiatry 7(5):e1135","journal-title":"Translational psychiatry"},{"key":"4847_CR10","doi-asserted-by":"crossref","unstructured":"Lei AA, Phang VWX, Lee YZ, Kow ASF, Tham CL, Ho YC et al (2025) Chronic stress-associated depressive disorders: the impact of HPA axis dysregulation and neuroinflammation on the hippocampus-A Mini Review. International journal of molecular sciences. ;26(7)","DOI":"10.3390\/ijms26072940"},{"issue":"15","key":"4847_CR11","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1016\/j.neuron.2021.05.017","volume":"109","author":"TC Bienvenu","year":"2021","unstructured":"Bienvenu TC, Dejean C, Jercog D, Aouizerate B, Lemoine M, Herry C (2021) The advent of fear conditioning as an animal model of post-traumatic stress disorder: Learning from the past to shape the future of PTSD research. Neuron 109(15):2380\u20132397","journal-title":"Neuron"},{"key":"4847_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1749-6632.2009.04979.x","volume":"1179","author":"R Yehuda","year":"2009","unstructured":"Yehuda R (2009) Status of glucocorticoid alterations in post-traumatic stress disorder. Ann N Y Acad Sci 1179:56\u201369","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"4847_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/npp.2015.171","volume":"41","author":"BS McEwen","year":"2016","unstructured":"McEwen BS, Nasca C, Gray JD (2016) Stress Effects on Neuronal Structure: Hippocampus, Amygdala, and Prefrontal Cortex. Neuropsychopharmacology: official publication Am Coll Neuropsychopharmacol 41(1):3\u201323","journal-title":"Neuropsychopharmacology: official publication Am Coll Neuropsychopharmacol"},{"issue":"1","key":"4847_CR14","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/npp.2016.146","volume":"42","author":"V Michopoulos","year":"2017","unstructured":"Michopoulos V, Powers A, Gillespie CF, Ressler KJ, Jovanovic T (2017) Inflammation in fear-and anxiety-based disorders: PTSD, GAD, and beyond. Neuropsychopharmacology: official publication Am Coll Neuropsychopharmacol 42(1):254\u2013270","journal-title":"Neuropsychopharmacology: official publication Am Coll Neuropsychopharmacol"},{"issue":"3","key":"4847_CR15","doi-asserted-by":"publisher","first-page":"R223","DOI":"10.1530\/JME-14-0011","volume":"52","author":"D Cuevas-Ramos","year":"2014","unstructured":"Cuevas-Ramos D, Fleseriu M (2014) Somatostatin receptor ligands and resistance to treatment in pituitary adenomas. J Mol Endocrinol 52(3):R223\u2013R240","journal-title":"J Mol Endocrinol"},{"key":"4847_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fnins.2017.00231","volume":"11","author":"A Stengel","year":"2017","unstructured":"Stengel A, Tach\u00e9 YF (2017) Activation of brain somatostatin signaling suppresses CRF receptor-mediated stress response. Front NeuroSci 11:231","journal-title":"Front NeuroSci"},{"key":"4847_CR17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.neuropharm.2015.09.021","volume":"101","author":"B Scheich","year":"2016","unstructured":"Scheich B, Gaszner B, Kormos V, L\u00e1szl\u00f3 K, \u00c1dori C, Borb\u00e9ly \u00c9 et al (2016) Somatostatin receptor subtype 4 activation is involved in anxiety and depression-like behavior in mouse models. Neuropharmacology 101:204\u2013215","journal-title":"Neuropharmacology"},{"key":"4847_CR18","doi-asserted-by":"crossref","unstructured":"Yamamoto M, Ben-Shlomo A, Kameda H, Fukuoka H, Deng N, Ding Y et al (2018) Somatostatin receptor subtype 5 modifies hypothalamic-pituitary-adrenal axis stress function. JCI insight. 3(19) :1-17.","DOI":"10.1172\/jci.insight.122932"},{"issue":"6","key":"4847_CR19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.eprac.2022.04.009","volume":"28","author":"KC Yuen","year":"2022","unstructured":"Yuen KC, Samson SL (2022) Oral octreotide: a review of recent clinical trials and practical recommendations for its use in the treatment of patients with acromegaly. Endocr Pract 28(6):637\u2013645","journal-title":"Endocr Pract"},{"issue":"4","key":"4847_CR20","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1007\/s12094-024-03732-w","volume":"27","author":"B Kiesewetter","year":"2025","unstructured":"Kiesewetter B, Pfl\u00fcger FF, Melhorn P, Mazal P, Raderer M (2025) Long-term experience with octreotide and lanreotide for the treatment of gastroenteropancreatic neuroendocrine tumors. Clin translational oncology: official publication Federation Span Oncol Soc Natl Cancer Inst Mexico 27(4):1642\u20131652","journal-title":"Clin translational oncology: official publication Federation Span Oncol Soc Natl Cancer Inst Mexico"},{"key":"4847_CR21","doi-asserted-by":"publisher","first-page":"102560","DOI":"10.1016\/j.ctrv.2023.102560","volume":"117","author":"A La Salvia","year":"2023","unstructured":"La Salvia A, Modica R, Rossi RE, Spada F, Rinzivillo M, Panzuto F et al (2023) Targeting neuroendocrine tumors with octreotide and lanreotide: Key points for clinical practice from NET specialists. Cancer Treat Rev 117:102560","journal-title":"Cancer Treat Rev"},{"issue":"9","key":"4847_CR22","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3748\/wjg.v17.i9.1135","volume":"17","author":"NN Nassar","year":"2011","unstructured":"Nassar NN, Schaalan MF, Zaki HF, Abdallah DM (2011) Octreotide ameliorates gastric lesions in chronically mild stressed rats. World J Gastroenterol 17(9):1135\u20131142","journal-title":"World J Gastroenterol"},{"issue":"6","key":"4847_CR23","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s12192-018-0929-7","volume":"23","author":"NM Aziz","year":"2018","unstructured":"Aziz NM, Ragy MM, Ahmed SM (2018) Somatostatin analogue, Octreotide, improves restraint stress-induced liver injury by ameliorating oxidative stress, inflammatory response, and activation of hepatic stellate cells. Cell stress chaperones 23(6):1237\u20131245","journal-title":"Cell stress chaperones"},{"issue":"6","key":"4847_CR24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.eprac.2022.04.009","volume":"28","author":"KCJ Yuen","year":"2022","unstructured":"Yuen KCJ, Samson SL, Oral Octreotide (2022) A review of recent clinical trials and practical recommendations for its use in the treatment of patients with acromegaly. Endocr practice: official J Am Coll Endocrinol Am Association Clin Endocrinologists 28(6):637\u2013645","journal-title":"Endocr practice: official J Am Coll Endocrinol Am Association Clin Endocrinologists"},{"key":"4847_CR25","unstructured":"Moore MJ, Shawler E, Jordan CH, Jackson CA (2025) Veteran and Military Mental Health Issues. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Evan Shawler declares no relevant financial relationships with ineligible companies. Disclosure: Christopher Jordan declares no relevant financial relationships with ineligible companies. Disclosure: Christopher Jackson declares no relevant financial relationships with ineligible companies.: StatPearls Publishing Copyright \u00a9. StatPearls Publishing LLC.; 2025"},{"key":"4847_CR26","unstructured":"Care IoLARCo, Animals UoL. Guide for the care and use of laboratory animals: US Department of Health and Human Services, Public Health Service, National &#8230"},{"key":"4847_CR27","doi-asserted-by":"crossref","unstructured":"Seibenhener ML, Wooten MC (2015) Use of the open field maze to measure locomotor and anxiety-like behavior in mice. J visualized experiments: JoVE. (96):e52434","DOI":"10.3791\/52434-v"},{"issue":"1\u20133","key":"4847_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","volume":"463","author":"L Prut","year":"2003","unstructured":"Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463(1\u20133):3\u201333","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"4847_CR29","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.pbb.2010.09.013","volume":"97","author":"AA Braun","year":"2011","unstructured":"Braun AA, Skelton MR, Vorhees CV, Williams MT (2011) Comparison of the elevated plus and elevated zero mazes in treated and untreated male Sprague-Dawley rats: effects of anxiolytic and anxiogenic agents. Pharmacol Biochem Behav 97(3):406\u2013415","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"4847_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/BF02244871","volume":"116","author":"JK Shepherd","year":"1994","unstructured":"Shepherd JK, Grewal SS, Fletcher A, Bill DJ, Dourish CT (1994) Behavioural and pharmacological characterisation of the elevated zero-maze as an animal model of anxiety. Psychopharmacology 116(1):56\u201364","journal-title":"Psychopharmacology"},{"issue":"10","key":"4847_CR31","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1111\/j.1460-9568.2003.02986.x","volume":"18","author":"S Jessberger","year":"2003","unstructured":"Jessberger S, Kempermann G (2003) Adult-born hippocampal neurons mature into activity-dependent responsiveness. Eur J Neurosci 18(10):2707\u20132712","journal-title":"Eur J Neurosci"},{"key":"4847_CR32","first-page":"23","volume-title":"Neuroproteomics","author":"S Spijker","year":"2011","unstructured":"Spijker S (2011) Dissection of rodent brain regions. In: Li KW (ed) Neuroproteomics. Humana, New York\/Heidelberg, pp 23\u201326. (Neuromethods; 57)."},{"key":"4847_CR33","doi-asserted-by":"publisher","first-page":"1112837","DOI":"10.3389\/fnbeh.2023.1112837","volume":"17","author":"K Shanazz","year":"2023","unstructured":"Shanazz K, Nalloor R, Lucas R, Vazdarjanova A (2023) Neuroinflammation is a susceptibility factor in developing a PTSD-like phenotype. Front Behav Neurosci 17:1112837","journal-title":"Front Behav Neurosci"},{"issue":"10","key":"4847_CR34","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.biopsych.2017.11.019","volume":"83","author":"J Deslauriers","year":"2018","unstructured":"Deslauriers J, Toth M, Der-Avakian A, Risbrough VB (2018) Current status of animal models of posttraumatic stress disorder: behavioral and biological phenotypes, and future challenges in improving translation. Biol Psychiatry 83(10):895\u2013907","journal-title":"Biol Psychiatry"},{"key":"4847_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2045-5380-2-9","volume":"2","author":"JP Hayes","year":"2012","unstructured":"Hayes JP, Hayes SM, Mikedis AM (2012) Quantitative meta-analysis of neural activity in posttraumatic stress disorder. Biology mood anxiety disorders 2:9","journal-title":"Biology mood anxiety disorders"},{"issue":"1","key":"4847_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1037\/a0038039","volume":"141","author":"JC Scott","year":"2015","unstructured":"Scott JC, Matt GE, Wrocklage KM, Crnich C, Jordan J, Southwick SM et al (2015) A quantitative meta-analysis of neurocognitive functioning in posttraumatic stress disorder. Psychol Bull 141(1):105","journal-title":"Psychol Bull"},{"issue":"1","key":"4847_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neuron.2016.09.039","volume":"92","author":"I Liberzon","year":"2016","unstructured":"Liberzon I, Abelson JL (2016) Context processing and the neurobiology of post-traumatic stress disorder. Neuron 92(1):14\u201330","journal-title":"Neuron"},{"key":"4847_CR38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.psyneuen.2016.11.031","volume":"76","author":"D Lindqvist","year":"2017","unstructured":"Lindqvist D, Dhabhar FS, James SJ, Hough CM, Jain FA, Bersani FS et al (2017) Oxidative stress, inflammation and treatment response in major depression. Psychoneuroendocrinology 76:197\u2013205","journal-title":"Psychoneuroendocrinology"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04847-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-026-04847-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04847-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:20:27Z","timestamp":1787566827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-026-04847-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4847"],"URL":"https:\/\/doi.org\/10.1007\/s11064-026-04847-y","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"7 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were in accordance with the institutional guidelines for animal experimentation and approved by ethics committee of the Baqiyatallah University of Medical Sciences. This study was reported in accordance with ARRIVE guidelines.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"224"}}